Mucinex D Tablet, Extended Release
NDC Package 63824-041-71

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Mucinex D (guaifenesin and pseudoephedrine hydrochloride) tablets is do not crush, chew, or break tablettake with a full glass of waterthis product can be administered without regard for timing of mealsadults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hourschildren under 12 years of age: do not use. This formulation utilizes a tablet, extended release delivery system. Marketed by Reckitt Benckiser Llc, this product is identified by NDC 63824-041 and is authorized under FDA application NDA021585.

Identification & Billing

NDC Package Code
63824-041-71
Package Description
24 POUCH in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 POUCH
Product Code
63824-041
11-Digit Billing Format
63824004171
RxNorm Crosswalk
  • RxCUI: 1244675 - guaiFENesin 1200 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet
  • RxCUI: 1244675 - 12 HR guaifenesin 1200 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Mucinex D Maximum Strength
Non-Proprietary Name
Guaifenesin And Pseudoephedrine Hydrochloride
Substance Name
Guaifenesin; Pseudoephedrine Hydrochloride
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not crush, chew, or break tablettake with a full glass of waterthis product can be administered without regard for timing of mealsadults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hourschildren under 12 years of age: do not use

Regulatory & Marketing

Labeler Name
Reckitt Benckiser Llc
Product Type
Human Otc Drug
FDA Application #
NDA021585
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-26-2012
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63824-041). Click a package code to view its specific billing and regulatory data.

63824-041-12
1 BLISTER PACK in 1 CARTON / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
63824-041-24
2 BLISTER PACK in 1 CARTON / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
63824-041-36
3 BLISTER PACK in 1 CARTON / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63824-041-71 identifies a specific commercial package of 24 pouch in 1 carton / 1 tablet, extended release in 1 pouch of Mucinex D Maximum Strength, a human over the counter drug labeled by Reckitt Benckiser Llc. This tablet, extended release is formulated for oral use and contains guaifenesin; pseudoephedrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reckitt Benckiser Llc on June 26, 2012. The current certification is valid through December 31, 2027.

How is this Reckitt Benckiser Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63824004171. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63824-041-71
11-Digit CMS (5-4-2)
63824-0041-71

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.